Gliomas are the most common primary brain tumors. Selective acidification of cancerous tissue induced pharmacologically may slow tumor growth and can be detected using magnetic resonance imaging (MRI). The sodium proton exchanger inhibitor cariporide can selectively acidify U87MG gliomas in mice. This study aimed to determine whether cariporide could selectively acidify C6 glioma tumors in rats with an intact immune system. C6 glioma cells were implanted in the right brain hemisphere of ten male Wistar rats. Chemical exchange saturation transfer (CEST) MRI (9.4T) was acquired on days 7–8 (N= 10) and 14–15 (N= 10) after implantation to measure in vivo tissue intracellular pH (pHi) within the tumors and on the contralateral side. Intracellular pH was basic relative to contralateral tissue at both time points (p < 0.05) assessed using the amine and amide concentration-independent detection (AACID) value. On day 14–15, measurements were made before and up to 160 minutes after cariporide injection (N= 6, dose: 6 mg/kg in 2 mL with 10% DMSO). Twenty minutes after drug injection, the average AACID value in the tumor significantly increased by ∼6.4% compared to pre-injection, corresponding to 0.31 ± 0.20 lower pHi, while in contralateral tissue, AACID value increases significantly by ∼4.3% compared to pre-injection, corresponding to 0.22 ± 0.19 lower pHi. Then the average AACID value returned to the baseline level in both tissues about an hour after the injection before trending back up in contralateral tissue 80 minutes and 100 minutes after injection. Control rats without tumors showed no changes following injection of cariporide in 10% or 1% DMSO. This study demonstrates the sensitivity of CEST-based pH-weighted imaging for monitoring the response of tumors to pharmacologically induced acidification. Although cariporide did induce intracellular acidification in the C6 glioma, this acidification was not tumor selective in this model.
Acidification of cancerous tissue induced pharmacologically may slow tumor growth and can be detected using magnetic resonance imaging. Numerous studies have shown that pharmacologically inhibiting specific transporters, such as the Na+/H+ exchanger 1 (NHE1), can alter glycolitic metabolism and affect tumor acidosis. The sodium proton exchanger inhibitor Cariporide can acidify U87MG gliomas in mice. This study aimed to determine whether Cariporide could acidify C6 glioma tumors in rats with an intact immune system. C6 glioma cells were implanted in the right brain hemisphere of ten rats. Chemical exchange saturation transfer (CEST) MRI (9.4T) was acquired on days 7–8 and 14–15 after implantation to measure in vivo tissue intracellular pH (pHi) within the tumors and on the contralateral side. pHi was basic relative to contralateral tissue at both time points assessed using the amine and amide concentration-independent detection (AACID) value. On day 14–15, measurements were made before and up to 160 min after Cariporide injection (N = 6). Twenty minutes after drug injection, the average AACID value in the tumor significantly increased by ∼6.4% compared to pre-injection, corresponding to 0.31 ± 0.20 lower pHi, while in contralateral tissue, AACID value increased significantly by ∼4.3% compared to pre-injection, corresponding to 0.22 ± 0.19 lower pHi. Control rats without tumors showed no changes following injection of Cariporide dissolved in 10% or 1% DMSO and diluted in PBS. This study demonstrates the sensitivity of CEST-based pH-weighted imaging for monitoring the response of tumors to pharmacologically induced acidification.
Our objective was to acidify rat C6 gliomas by inhibiting NHE1 with cariporide and to monitor the pH changes with AACID-CEST MRI. AACID-CEST MRI was successfully used to monitor changes in tumor pHi over time after cariporide injection. Our results showed a pH decrease in both the tumor and the contralateral tissue following cariporide injection. CEST-MRI measurement of tumor response pH could help to enhance the efficacy of this treatment paradigm in different human malignancies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.